Universität Wien
Warning! The directory is not yet complete and will be amended until the beginning of the term.

322052 VO Nucleic Acid-Therapeutics: Antisense, RNA Interference, CRISPR - M14 (2017W)

1.00 ECTS (1.00 SWS), SPL 32 - Pharmazie

Beginn: 09.10.2017
Ende: 20.11.2017

Jeden Montag 16.30 - 18:00 Uhr im Raum 2D313
Moodle

Details

Language: German

Examination dates

Lecturers

Classes (iCal) - next class is marked with N

  • Monday 09.10. 16:30 - 18:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Monday 16.10. 16:30 - 18:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Monday 23.10. 16:30 - 18:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Monday 30.10. 16:30 - 18:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Monday 06.11. 16:30 - 18:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Monday 13.11. 16:30 - 18:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Monday 20.11. 16:30 - 18:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II

Information

Aims, contents and method of the course

The course is mainly directed to advanced students of pharmacy or related curricula, and to doctoral students. Basic knowledge of biochemistry, pharmacology, and organic chemistry is required.

The course will be held in German.

Assessment and permitted materials

written examination
e-learning task

Minimum requirements and assessment criteria

Examination topics

Reading list

Association in the course directory

A400, MA23

Last modified: Sa 02.04.2022 00:27